Arbutus Biopharma Corporation (NASDAQ: ABUS) has announced new data from its im-Prove I Phase 2a clinical trial (AB-729-201) showing significant progress in achieving a functional cure for patients ...

Plexus Corp. attributed the decrease in net sales to market-driven inventory corrections and weaker customer demand, particularly in the Healthcare/Life Sciences and Industrial market sectors. The ...

Fluence Energy shares slid -7.1% this afternoon. Here's what you need to know about the Mid-CapUtilities - renewable company: ...

PTC Inc. has recently released its 10-K report, detailing its financial performance for the fiscal year ending September 30, ...

It's important to note that the termination of Capital One's Walmart program agreement, effective May 21, 2024, increased the ...

One of the losers of today's trading session was Repligen. Shares of the Biotechnology company plunged -14.2%, and some ...

Nu Holdings Ltd. provides digital banking platform in Brazil, Mexico, Colombia, Cayman Islands, Germany, Argentina, the ...

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...

This morning we watched Applied Materials drop -8.0% to a price of $171.06 per share. The Large-Cap Semiconductors company is ...

In the third quarter of 2024, Advance Auto Parts reported net sales of $2.15 billion, a decrease of 3.2% compared with the ...

The 16 analysts following MPLX LP have set target prices ranging from $43.0 to $55.0 per share, for an average of $48.87 with ...

As a result of these announcements, the company's shares have moved 15.6% on the market, and are now trading at a price of ...